SEC Form 4 · accession 0001735276-18-000035
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laurie Keating
Officer — SVP, GC & Secretary
Period of report
Apr 16, 2018
Accepted (ET)
Jun 22, 2018 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2018 | M | 1,563 | $42.22 | A | 16,063 | D | |
| Common StockF2 | Jun 20, 2018 | S | 1,563 | $105.04 | D | 14,500 | D | |
| Common StockF3 | Apr 16, 2018 | J | 31 | $0.00 | A | 288 | I | by Managed Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $42.22 | Jun 20, 2018 | M | 1,563 | D | — | Dec 20, 2026 | Common Stock | 1,563 | 15,626 | D |
Explanation of responses
- F1All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2017.
- F2Sale prices ranged from $104.73 to $105.35
- F3Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- F4The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.